These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2981652)

  • 1. Cardiovascular properties of metkephamid, a delta opioid receptor agonist, in man.
    Pasanisi F; Sloan L; Rubin PC
    Clin Sci (Lond); 1985 Feb; 68(2):209-13. PubMed ID: 2981652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-tolerance studies distinguish morphine- and metkephamid-induced analgesia.
    Hynes MD; Frederickson RC
    Life Sci; 1982 Sep 20-27; 31(12-13):1201-4. PubMed ID: 6292609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diuresis and suppression of vasopressin by kappa opioids: comparison with mu and delta opioids and clonidine.
    Leander JD; Zerbe RL; Hart JC
    J Pharmacol Exp Ther; 1985 Aug; 234(2):463-9. PubMed ID: 2991502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential cardiovascular and respiratory responses to central administration of selective opioid agonists in conscious rabbits: correlation with receptor distribution.
    May CN; Dashwood MR; Whitehead CJ; Mathias CJ
    Br J Pharmacol; 1989 Nov; 98(3):903-13. PubMed ID: 2556206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of metkephamid (LY127623), a selective delta opioid receptor agonist, on gastric function.
    Glavin GB; Pinsky C; Hall AM
    Life Sci; 1990; 46(15):1075-9. PubMed ID: 2159095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-tolerance to metkephamid (LY127623) produced by morphine solution ingestion by mice.
    Leander JD
    Alcohol Drug Res; 1987; 7(5-6):321-5. PubMed ID: 3040022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of central muscarinic-1 receptor stimulation on blood pressure regulation.
    Medina A; Bodick N; Goldberger AL; Mac Mahon M; Lipsitz LA
    Hypertension; 1997 Mar; 29(3):828-34. PubMed ID: 9052903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metkephamid (Tyr-D-ala-Gly-Phe-N(Me)Met-NH2), a potent opioid peptide: receptor binding and analgesic properties.
    Burkhardt C; Frederickson RC; Pasternak GW
    Peptides; 1982; 3(5):869-71. PubMed ID: 6294639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioids preserve the adrenal medullary response evoked by severe hemorrhage: studies on adrenal catecholamine and met-enkephalin secretion in halothane anesthetized cats.
    Gaumann DM; Yaksh TL; Tyce GM; Lucas DL
    Anesthesiology; 1988 May; 68(5):743-53. PubMed ID: 2835918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of endorphins on heart rate and blood pressure in adult dogs.
    Haddad GG; Jeng HJ; Lai TL
    Am J Physiol; 1986 May; 250(5 Pt 2):H796-805. PubMed ID: 3518492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic and humoral effects at rest and after head-up tilt tests during 24-hour infusion of a new nitrate ester, ITF 296, compared with ISDN and placebo in healthy volunteers: a double-blind, randomized, within-subject study.
    Sardina M; Warrington SJ; Boyce M; Johnston A; Bianchini C
    J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S80-90. PubMed ID: 8839231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional haemodynamic effects of mu-, delta-, and kappa-opioid agonists microinjected into the hypothalamic paraventricular nuclei of conscious, unrestrained rats.
    Bachelard H; Pître M
    Br J Pharmacol; 1995 Jun; 115(4):613-21. PubMed ID: 7582480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of ventilation and oxygen consumption by delta- and mu-opioid receptor agonists.
    Schaeffer JI; Haddad GG
    J Appl Physiol (1985); 1985 Sep; 59(3):959-68. PubMed ID: 2997105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metkephamid, a systemically active analog of methionine enkephalin with potent opioid alpha-receptor activity.
    Frederickson RC; Smithwick EL; Shuman R; Bemis KG
    Science; 1981 Feb; 211(4482):603-5. PubMed ID: 6256856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of opioid receptors on gastric muscle cells by selective receptor protection.
    Grider JR; Makhlouf GM
    Am J Physiol; 1991 Jan; 260(1 Pt 1):G103-7. PubMed ID: 1670978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sympathoadrenal, cardiovascular and blood gas responses to highly selective mu and delta opioid peptides.
    Kiritsy-Roy JA; Marson L; Van Loon GR
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1096-103. PubMed ID: 2557411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mu-receptors mediate opioid cardiovascular effects at anterior hypothalamic sites through sympatho-adrenomedullary and parasympathetic pathways.
    Pfeiffer A; Feuerstein G; Zerbe RL; Faden AI; Kopin IJ
    Endocrinology; 1983 Sep; 113(3):929-38. PubMed ID: 6307671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid control of the ruminant stomach motility: functional importance of mu, kappa and delta receptors.
    Ruckebusch Y; Bardon T; Pairet M
    Life Sci; 1984 Oct; 35(17):1731-8. PubMed ID: 6090847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous opioids and baroreflex control in humans.
    Rubin PC; McLean K; Reid JL
    Hypertension; 1983; 5(4):535-8. PubMed ID: 6862578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central effects of mu, delta, and kappa receptor agonists in hemorrhagic shock.
    Feuerstein G; Powell E; Faden AI
    Peptides; 1985; 6 Suppl 1():11-3. PubMed ID: 2995939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.